Workshop on the therapeutic use of bacteriophages

• Date:
  Monday, 08 June 2015
• Location:
  European Medicines Agency, Amsterdam, the Netherlands

On 8 June 2015, the European Medicines Agency is organising a workshop on the therapeutic use of bacteriophages, bringing together experts and stakeholders from the academic, industrial and regulatory sectors to discuss different aspects of using bacteriophages to treat bacterial infections. The aim is to proactively discuss current issues and open questions and reflect on potential ways forward for this therapy with various stakeholders.

Documents

Workshop on the therapeutic use of bacteriophages - Summary

Reference Number: EMA/389257/2015

Agenda - Workshop on the therapeutic use of bacteriophages

Reference Number: EMA/265715/2015 Corr.

Presentation - A historical overview of the therapeutic use of bacteriophages (Andrzej Gorski)

Presentation - GMP phage production for clinical trials (Frenk Smrekar)

Presentation - GMP phage production for clinical trials (Laurent Bretaudeau)

Presentation - Current issues on quality of phage products (Alan Fauconnier)

Presentation - Changing phage cocktails to match developing resistance (Gilbert Verbeken)

Presentation - Considerations on regulatory aspects (Zigmars Sebris)

Presentation - Current clinical evidence for the therapeutic use of bacteriophages (Xavier Wittebole)

Presentation - Experience from the ongoing Phagoburn clinical trial (Patrick Jault)

Presentation - Experience from the Phagorburn clinical trial (Jerome Gabard)

Multimedia